New filler aims to reshape aging chins without surgery

NCT ID NCT05986630

Ongoing Symptom relief Sponsor: Teoxane SA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a hyaluronic acid filler called TEOSYAL TPVM against another filler for improving chin shape and lower face aging. About 155 healthy adults with moderate to severe chin retrusion will receive injections, with an optional touch-up at 4 weeks. The main goal is to see if TEOSYAL is as good as the comparator at reducing chin retrusion 8 weeks after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TEOSYAL TPVM (hyaluronic acid dermal filler)
What this could lead to: If successful, this could offer a safe, effective option for non-surgical chin enhancement and lower face rejuvenation.
What could go wrong: This is a cosmetic study, not a treatment for a medical condition. Results may not apply to all skin types or ages, and fillers carry risks like swelling, bruising, or asymmetry.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING CHIN RETRUSION

Contacts and locations

Locations

Care- Geneva

Geneva, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.